Riluzole Augmentation Pilot in Depression (RAPID) Trial (RAPID)
Sponsor: Brigham and Women's Hospital
Terminated
PI departure, slow recruitment
Other terminated trials from Brigham and Women's Hospital
Other Major Depressive Disorder trials with similar outcome
Listed as NCT01703039, this PHASE2 trial focuses on Major Depressive Disorder and remains terminated or withdrawn. Sponsored by Brigham and Women's Hospital, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Terminated PHASE2
-
May 2019 — Sep 2019 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — May 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .